Fifth Third Bancorp Halozyme Therapeutics, Inc. Transaction History

Fifth Third Bancorp

$28.3 Billion
Q2 2025

A detailed history of Fifth Third Bancorp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 5,852 shares of HALO stock, worth $391,908. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,852

Previous 10,017 41.58%

Holding current value

$391,908

Previous $639,000 52.43%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$47.91 - $70.14 $199,545 - $292,133	-4,165 Reduced 41.58%	5,852 $304,000
Q1 2025 Apr 15, 2025	BUY	$47.74 - $65.16 $108,656 - $148,304	2,276 Added 29.4%	10,017 $639,000
Q4 2024 Jan 21, 2025	SELL	$42.57 - $61.09 $2,469 - $3,543	-58 Reduced 0.74%	7,741 $370,000
Q3 2024 Oct 17, 2024	SELL	$51.3 - $64.42 $174,779 - $219,478	-3,407 Reduced 30.4%	7,799 $446,000
Q2 2024 Jul 22, 2024	BUY	$37.81 - $52.4 $9,868 - $13,676	261 Added 2.38%	11,206 $586,000
Q1 2024 Apr 23, 2024	SELL	$33.68 - $41.95 $842 - $1,048	-25 Reduced 0.23%	10,945 $445,000
Q4 2023 Jan 19, 2024	SELL	$33.32 - $42.1 $43,049 - $54,393	-1,292 Reduced 10.54%	10,970 $405,000
Q3 2023 Oct 31, 2023	BUY	$36.46 - $44.03 $11,229 - $13,561	308 Added 2.58%	12,262 $468,000
Q2 2023 Jul 25, 2023	BUY	$30.28 - $38.74 $54,352 - $69,538	1,795 Added 17.67%	11,954 $431,000
Q1 2023 Apr 24, 2023	SELL	$32.86 - $55.7 $89,576 - $151,838	-2,726 Reduced 21.16%	10,159 $387,000
Q4 2022 Jan 25, 2023	SELL	$40.06 - $59.44 $46,069 - $68,356	-1,150 Reduced 8.19%	12,885 $0
Q3 2022 Oct 25, 2022	SELL	$38.53 - $51.78 $346 - $466	-9 Reduced 0.06%	14,035 $555,000
Q2 2022 Aug 04, 2022	SELL	$37.35 - $48.3 $1,792 - $2,318	-48 Reduced 0.34%	14,044 $618,000
Q1 2022 Apr 19, 2022	BUY	$31.97 - $41.06 $73,499 - $94,396	2,299 Added 19.49%	14,092 $562,000
Q4 2021 Feb 01, 2022	BUY	$31.82 - $40.75 $16,991 - $21,760	534 Added 4.74%	11,793 $474,000
Q3 2021 Oct 15, 2021	BUY	$38.47 - $46.42 $16,041 - $19,357	417 Added 3.85%	11,259 $458,000
Q2 2021 Aug 06, 2021	BUY	$38.84 - $51.31 $16,701 - $22,063	430 Added 4.13%	10,842 $492,000
Q1 2021 May 07, 2021	BUY	$39.51 - $51.45 $22,046 - $28,709	558 Added 5.66%	10,412 $434,000
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $110,931 - $187,478	4,298 Added 77.36%	9,854 $421,000
Q3 2020 Nov 09, 2020	BUY	$25.74 - $29.63 $139,536 - $160,624	5,421 Added 4015.56%	5,556 $146,000
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $2,015 - $2,636	135 New	135 $2,000
Q4 2017 Feb 14, 2018	SELL	$16.75 - $20.8 $33,500 - $41,600	-2,000 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	2,000	2,000 $26,000

Others Institutions Holding HALO

# of Institutions

605

Shares Held

127M

Call Options Held

408K

Put Options Held

388K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.33B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Halozyme Therapeutics, Inc. Transaction History